TABLE 2.
Total |
Stage II |
Stage III |
||||
---|---|---|---|---|---|---|
No. | % | No. | % | No. | % | |
Total | 2886 | 100.0 | 1524 | 100.0 | 1362 | 100.0 |
Rates of | ||||||
Radiation therapy receipt* | 1573 | 54.5 | 732 | 48.0 | 841 | 61.8 |
Chemotherapy receipt* | 1502 | 52.0 | 641 | 42.1 | 861 | 63.2 |
Both radiation therapy and chemotherapy receipt* | 1309 | 45.4 | 571 | 37.5 | 738 | 54.2 |
Among those receiving adjuvant radiation therapy | ||||||
Receiving neoadjuvant radiation therapy* | 306 | 19.4 | 191 | 26.1 | 115 | 13.7 |
Initiation of radiation therapy before or within 8 wk of resection* | 1006 | 64.0 | 509 | 69.5 | 497 | 59.1 |
Among those receiving adjuvant chemotherapy | ||||||
Receiving neoadjuvant chemotherapy* | 198 | 13.2 | 127 | 19.8 | 71 | 8.2 |
Initiation of chemotherapy before or within 8 wk of resection† | 1176 | 78.3 | 483 | 75.4 | 693 | 80.5 |
All chi-square overall, comparing stage II with stage III with different characteristics of therapy. (No statistics for testing duration of therapy.)
P ≤.001.
P ≤.05.